Basic information Physical Form Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  (S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol

(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol

Basic information Physical Form Safety Supplier Related

(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol Basic information

Product Name:
(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol
Synonyms:
  • (S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol
  • EOS-60623
  • Benzenemethanol, 5-fluoro-2-iodo-α-methyl-, (αS)-
  • (S)-1-(2-Iodo-5-fluorophenyl)-ethanol
  • (1S)-1-(5-FLUORO-2-IODOPHENYL)ETHAN-1-OL
  • -1-(5-fluoro-2-iodophenyl)ethan-1-ol
  • (1S)-1-(5-fluoro-2-iodophenyl)ethanol
  • (S)-5-Fluoro-2-iodo-alpha-methylbenzyl Alcohol
CAS:
1454847-96-1
MF:
C8H8FIO
MW:
266.05
Mol File:
1454847-96-1.mol
More
Less

(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol Chemical Properties

Boiling point:
275.7±30.0 °C(Predicted)
Density 
1.812±0.06 g/cm3(Predicted)
pka
13.80±0.20(Predicted)
More
Less

(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol Usage And Synthesis

Physical Form

Solid or liquid

Uses

(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol is an intermediate of Lorlatinib, which is an orally administered inhibitor of ALK and ROS1, two enzymes that play a role in the development of cancer.

Synthesis

(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol is synthesised using 5'-Fluoro-2'-iodoacetophenone as a raw material by chemical reaction. The specific synthesis steps are as follows:
A solution of (-)-DIPCI (57.1 g, 178 mmol) in THF (100 ml) was cooled to -20 to -30 C. A solution of compound 1 (31 .3 g, 1 19 mmol) in THF (100 ml) was then added dropwise, via addition funnel (30 min addition). The reaction was left to warm up to RT. After 2 h, the reaction was cooled to -30 C and another portion of (-)-DIPCI (38.0 g, 1 19 mmol) was added. After 30 min, the reaction was allowed to warm to RT and after 1 h, the solvents were removed in vacuo and the residue re-dissolved in MTBE (200 ml). A solution of diethanolamine (31 g, 296 mmol) in ethanol/THF (15 ml/30 ml) was added via addition funnel, to the reaction mixture under an ice bath. The formation of a white precipitate was observed. The suspension was heated at reflux for 2 hours then cooled to room temperature, filtered and the mother liquids concentrated in vacuo. The residue was suspended in heptane/EtOAc (7:3, 200 ml) and again filtered. This procedure was repeated until no more solids could be observed after the liquids were concentrated. The final yellow oil was purified by column chromatography (eluent: cyclohexane/EtOAc- 99:1 to 96:4). The resulting colorless oil was further purified by recrystallisation from heptanes, to give alcohol compound 2 (25 g, 80% yield, 99% purity and 96% ee) as white crystals. 1H NMR (400 MHz, CDCI3) delta 7.73 (dd, 1 H), 7.32 (dd, 1 H), 6.74 (ddd, 1 H), 4.99 - 5.04 (m, 1 H), 2.01 (d, 1 H), 1.44 (d, 3 H). LCMS-ES: No ionization, Purity 99%. Chiral GC (column CP-Chirasil-DexnCB): 96% ee; Rt (minor) 17.7 minutes and Rt (major) 19.4 minutes.

(S)-1-(5-fluoro-2-iodophenyl)ethan-1-olSupplier

Shanghai Tube Pharmaceutical Co., Ltd. Gold
Tel
021-54338626 18017892860
Email
sales@tubepharm.com
Hangzhou Chemtrue Bio-Tech Co.,Ltd. Gold
Tel
0571-86828652 18857119830
Email
sales@chemtrue-bio.com
Syncozymes (Shanghai) Co.,Ltd. Gold
Tel
021-68187180-819 13681683526
Email
lchen@syncozymes.com
Shanghai Lingfu Pharmaceutical Research Co. LTD Gold
Tel
400-8675577 19945755304
Email
sales@chemany.com
HeFei ShenShen Medical Technology Co.,Ltd Gold
Tel
15375050680; 15375050680
Email
gdz2.71828@163.com